Yes there has been trials - logic prevails anyway - TGA would not have approved it for usage if trials had not been done.
BIT's meteoric rise over the last couple of weeks has been on the back of very positive Phase 2 trial results - they still have to do Phase 3 research (maker or breaker). Which is why it's drug is not on the market.
